After $1M NEI Grant, ONL Therapeutics Closer to Clinical Trials
Xconomy ONL Therapeutics, the Ann Arbor, MI-based biotech startup working on sight-preserving therapies for patients with retinal diseases, is one step closer to clinical trials, thanks to a cash [...]
ONL Therapeutics Gets Federal Grant of $1 Million
Crain’s Company also raises $1 million to fund drug for patients with retinal detachments… Read the Article